MiniMed™ 780G System†
Available now with the Guardian™ 4 sensor!
For people living with Type 1 diabetes.
Auto
corrections ‡
Auto corrections help make up for carb counts that aren't always exact.*
Personalized
glucose targets
The MiniMed™ 780G system lets you select your glucose target (5.5, 6.1, or 6.7 mmol/L).
Spend more
Time in Range1
Self-adjusts insulin and corrects highs every 5 minutes* to help keep sugars in target range.
No fingersticks in SmartGuard feature**
Less to do, less to worry about. No calibrations** with the Guardian™ 4 sensor CGM.
SmartGuard™ Technology
The MiniMed™ 780G system with advanced SmartGuard™ tech provides you a more effortless way to stabilize your sugar levels. With new auto correction dosing, the system continuously checks your sugar levels and automatically adjusts insulin delivery and corrects highs to help keep you in range*.
Guardian™ 4 Sensor
Ask more of your CGM!
See how much more it can do as part of a system.
The Guardian™ 4 sensor continuous glucose monitor (CGM) measures your sugar levels every 5 minutes, sending levels to the MiniMed™ 780G insulin pump. Based on info received from the CGM, the pump makes automatic adjustments and corrections to your insulin delivery, helping to prevent highs and lows*. And with the Guardian™ 4 sensor, there are no fingersticks with SmartGuard™ technology**.
Our customers are getting it back with the MiniMed™ 780G system.
"It" is that thing – that one thing that’s uniquely yours. That one thing you love but feel like you don’t get to fully enjoy anymore. Or it’s missing because you’re so focused on your diabetes. Maybe that thing is spending time with loved ones or eating your favorite breakfast food. Our customers are discovering they can get some of these things back with the MiniMed™ 780G system. What will you get back?
Discover the latest in insulin pump technology!
No need to complete the form. Check your email inbox for your “Software Update Eligibility Message” or give us a call.
The MiniMed 780G insulin pump is indicated for use by patients age 7-80 years with Type 1 diabetes, whose total daily dose of insulin is 8 units per day or more.
† Licensed as MINIMED 780G SYSTEM and MINIMED 780G SYSTEM PRIME (A2).
*Refers to SmartGuard™ feature. Some user interaction required. Individual results may vary. Data on file. As of November 1, 2022
**A blood glucose (BG) reading is needed to enter SmartGuard™. If symptoms don’t match alerts & readings, use a BG meter. Refer to user guide. Pivotal trial participants spend avg of 95% in SmartGuard.
‡ Refers to auto correct, which provides bolus assistance. Can deliver all correction doses automatically without user interaction, feature can be turned on and off.
1. Data on file from CIP 321: Pivotal Trial (Age 14-75). N=152. 2020; 16 US sites